Skip to main content
Clinical Trials/NCT02283112
NCT02283112
Recruiting
Not Applicable

Validation of Drug Assays in Various Biological Matrices

University of Liverpool1 site in 1 country100 target enrollmentOctober 1, 2014
ConditionsInfection

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infection
Sponsor
University of Liverpool
Enrollment
100
Locations
1
Primary Endpoint
To measure drug concentrations using high performance liquid chromatography -tandem mass spectrometry (HPLC-MS/MS) (accuracy and precision of assays that measure drug concentrations)
Status
Recruiting
Last Updated
2 months ago

Overview

Brief Summary

This study aims to ensure that assays that measure drug concentrations are accurate and precise in different matrices when quantified using high performance liquid chromatography -tandem mass spectrometry (HPLC-MS/MS). The study involves collecting samples of various bodily fluids to quantify antimicrobials, antivirals, oral contraceptives and erectile dysfunction agents. Samples will also be obtained from individuals not receiving these medications for quality control purposes.

Registry
clinicaltrials.gov
Start Date
October 1, 2014
End Date
December 31, 2027
Last Updated
2 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor
Principal Investigator

Helen Reynolds

Research nurse

University of Liverpool

Eligibility Criteria

Inclusion Criteria

  • \> 18 years of age

Exclusion Criteria

  • Unable to give informed consent

Outcomes

Primary Outcomes

To measure drug concentrations using high performance liquid chromatography -tandem mass spectrometry (HPLC-MS/MS) (accuracy and precision of assays that measure drug concentrations)

Time Frame: Follow up up to 5 years

Assay validation

Study Sites (1)

Loading locations...

Similar Trials